Foley et al v. Bristol-Myers Squibb Company et al

Filing 27

MDL Conditional Transfer Order (CTO-1) transferring case to the Northern District of Florida. Signed by MDL on 10/14/2016. (Copies have been distributed pursuant to the NEF - SLD)

Case TNE/1:16-cv-00384 Document 3 Filed 10/14/16 Page 1 of 3

UNITED STATES JUDICIAL PANEL
on
MULTIDISTRICT LITIGATION

IN RE: ABILIFY (ARIPIPRAZOLE) PRODUCTS
LIABILITY LITIGATION

MDL No. 2734

(SEE ATTACHED SCHEDULE)

CONDITIONAL TRANSFER ORDER (CTO −1)

On October 3, 2016, the Panel transferred 20 civil action(s) to the United States District Court for
the Northern District of Florida for coordinated or consolidated pretrial proceedings pursuant to 28
U.S.C. § 1407. See _F.Supp.3d_ (J.P.M.L. 2016). Since that time, no additional action(s) have been
transferred to the Northern District of Florida. With the consent of that court, all such actions have
been assigned to the Honorable M. Casey Rodgers.
It appears that the action(s) on this conditional transfer order involve questions of fact that are
common to the actions previously transferred to the Northern District of Florida and assigned to
Judge Rodgers.
Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict
Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. § 1407 to the
Northern District of Florida for the reasons stated in the order of October 3, 2016, and, with the
consent of that court, assigned to the Honorable M. Casey Rodgers.
This order does not become effective until it is filed in the Office of the Clerk of the United States
District Court for the Northern District of Florida. The transmittal of this order to said Clerk shall be
stayed 7 days from the entry thereof. If any party files a notice of opposition with the Clerk of the
Panel within this 7−day period, the stay will be continued until further order of the Panel.

FOR THE PANEL:

Oct 14, 2016

Jeffery N. Lüthi
Clerk of the Panel

Case TNE/1:16-cv-00384 Document 3 Filed 10/14/16 Page 2 of 3

IN RE: ABILIFY (ARIPIPRAZOLE) PRODUCTS
LIABILITY LITIGATION

MDL No. 2734

SCHEDULE CTO−1 − TAG−ALONG ACTIONS

DIST

DIV.

C.A.NO.

CASE CAPTION

2

16−02744

Hedstrom v. Bristol−Myers Squibb Company et al

ARIZONA
AZ

CALIFORNIA CENTRAL
CAC

2

16−06606

CAC
CAC

2
8

16−06613
16−01789

Erma Jean Hudson v. Bristol−Myers Squibb Company
et al
Christina Platt v. Bristol−Myers Squibb Company et al
Ted John Elia v. Bristol−Myers Squibb Company et al

CALIFORNIA EASTERN
CAE

1

16−01479

Esquivel, et al. v. Bristol−Myers Squibb Company, et al.

1
1

16−01674
16−02396

Adams et al v. Bristol−Myers Squibb Company et al
Cho v. Bristol−Myers Squibb Company et al

16−01098

Campbell et al v. Bristol−Myers Squibb Co et al

16−02153

Roberts v. Bristol−Meyers Squibb Company et al

1

16−11533

Carlson v. Bristol−Myers Squibb Company et al

2
2

16−01596
16−01597

Foley et al v. Bristol−Myers Squibb Company et al
Stirling et al v. Bristol−Myers Squibb Company et al

COLORADO
CO
CO

CONNECTICUT
CT

3

FLORIDA MIDDLE
FLM

8

MASSACHUSETTS
MA
NEVADA
NV
NV

Case TNE/1:16-cv-00384 Document 3 Filed 10/14/16 Page 3 of 3
NEW JERSEY
NJ

3

16−05529

HIMEL v. BRISTOL−MYERS SQUIBB COMPANY et
al

NEW YORK SOUTHERN
NYS

1

16−06023

Groshans v. Bristol−Meyers Squibb Company et al

NORTH CAROLINA EASTERN
NCE

5

16−00749

Jahateh v. Bristol−Myers Squibb Company, et al

16−00384

Runninghorse v. Bristol−Myers Squibb Company et al

16−00976
16−01101

Chier v. Bristol−Myers Squibb Co et al
Armfield v. Bristol−Myers Squibb Company et al

TENNESSEE EASTERN
TNE

1

WISCONSIN EASTERN
WIE
WIE

2
2